Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 201 for melanoma

Edit search filters
  1. Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy

    Rochester, MN

  2. Establishment of a Biorepository of Baseline and Follow-up Saliva Samples Collected from Newly Diagnosed, Treatment-naïve Cancer Patients

    Jacksonville, FL

  3. Using Social Media for Public Health Education on Melanoma within the Hispanic Population

    Scottsdale/Phoenix, AZ

  4. Mayo Clinic Cancer Genomics Service Line Biorepository

    Eau Claire, WI, Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN

  6. Gut and Tumor Microbiome in Patients With Advanced ER-positive and HER2-negative Breast Cancer or Advanced Melanoma Undergoing PD-1 Checkpoint Inhibitor Therapy.

    Jacksonville, FL

  7. A Study of the Impact of Limiting PGY-1 General Surgery Residents to 16-hour Shifts with a Mandatory 8 Hours Between Shifts on Quality of Life, Health, Education, Hours Worked and Operations Performed.

    Scottsdale/Phoenix, AZ

  8. The Circulating Cell-free Genome Atlas Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC) (ACT-MBC)

    Eau Claire, WI, Mankato, MN, Rochester, MN, Albert Lea, MN

  10. A Study for Germline Mutations of Patients with Phyllodes Tumors of the Breast

    Rochester, MN

.

Mayo Clinic Footer